AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 171 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,842 | +80744.9% | 15,295 | 0.0% | 0.00% | – |
| Q2 2023 | $147 | -12.5% | 15,295 | 0.0% | 0.00% | – |
| Q1 2023 | $168 | +154.5% | 15,295 | +0.3% | 0.00% | – |
| Q4 2022 | $66 | -99.9% | 15,247 | 0.0% | 0.00% | – |
| Q3 2022 | $115,000 | -24.8% | 15,247 | -0.6% | 0.00% | – |
| Q2 2022 | $153,000 | -19.5% | 15,335 | 0.0% | 0.00% | – |
| Q1 2022 | $190,000 | -45.9% | 15,335 | 0.0% | 0.00% | – |
| Q4 2021 | $351,000 | -50.4% | 15,335 | -64.4% | 0.00% | -100.0% |
| Q3 2021 | $707,000 | +258.9% | 43,135 | +183.3% | 0.00% | – |
| Q2 2021 | $197,000 | +7.7% | 15,225 | +8.9% | 0.00% | – |
| Q1 2021 | $183,000 | +66.4% | 13,979 | +74.2% | 0.00% | – |
| Q4 2020 | $110,000 | -22.5% | 8,024 | -16.8% | 0.00% | – |
| Q3 2020 | $142,000 | -42.5% | 9,641 | -36.6% | 0.00% | -100.0% |
| Q2 2020 | $247,000 | +79.0% | 15,210 | +59.9% | 0.00% | – |
| Q1 2020 | $138,000 | -79.0% | 9,512 | -70.7% | 0.00% | -100.0% |
| Q4 2019 | $658,000 | +826.8% | 32,509 | +145.8% | 0.00% | – |
| Q3 2019 | $71,000 | -56.2% | 13,224 | -46.5% | 0.00% | – |
| Q2 2019 | $162,000 | +157.1% | 24,710 | +152.7% | 0.00% | – |
| Q1 2019 | $63,000 | +57.5% | 9,780 | +64.7% | 0.00% | – |
| Q4 2018 | $40,000 | +14.3% | 5,938 | +12.0% | 0.00% | – |
| Q3 2018 | $35,000 | +6.1% | 5,300 | -7.5% | 0.00% | – |
| Q2 2018 | $33,000 | – | 5,730 | +143150.0% | 0.00% | – |
| Q4 2016 | $0 | – | 4 | -94.1% | 0.00% | – |
| Q3 2016 | $0 | – | 68 | +423.1% | 0.00% | – |
| Q2 2016 | $0 | – | 13 | -63.9% | 0.00% | – |
| Q1 2016 | $0 | – | 36 | -29.4% | 0.00% | – |
| Q4 2015 | $0 | – | 51 | -1.9% | 0.00% | – |
| Q3 2015 | $0 | – | 52 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
| ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
| DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
| NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
| Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
| HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
| SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |